Iterum Therapeutics Plc (NASDAQ:ITRM) currently has a daily average trading volume of 2.26M but it saw 1518083 shares traded in last market. With a market cap of 29.29M USD, the company’s current market price of $1.29 came rising about 6.61 while comparing to the previous closing price of $1.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.50 and as low as $0.64. In the recent trading on the day, stock has struck highest price mark of $1.245 while lowest mark touched by it was $1.3291.
Taking a look at 20-day trading activity of Iterum Therapeutics Plc (ITRM) gives us an average price of $1.1390, while its current price level is -48.40% below from 52-week high level whereas it is 100.93% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1145 while that of 200 days or SMA-200 reads an average of $1.3564. A closer look into the stock’s movement over the week reveals that its volatility is standing at 35.52% during that period while stretching the period over a month that decreases to 15.27%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 53.71 which implies that the stock is in neutral territory.
H.C. Wainwright upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 15, 2021 while assigning a price target of $2.50. RBC Capital Mkts issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $7 and $2.
Over the week, ITRM’s stock price is moving 10.26% up while it is 22.86% when we observe its performance for the past one month. Year-to-date it is -34.52% down and over the past year, the stock is showing an upside performance of 95.45%.
Currently, Iterum Therapeutics Plc’s total number of outstanding shares is 22.71M. Company’s return on equity (ROE) at -555.68%. Stock’s beta reads 2.28. Its return on asset (ROA) is -86.93% on average.
